Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quanduzhong capsule vs Eucommia granules in essential hypertension with TCM kidney deficiency
ChiCTR2100045216Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Nov 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Quanduzhong in essential hypertension (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Clinic blood pressure. Started Nov 2020; status: recruiting.
02
Drugs
Quanduzhong
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2100045216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045216.